Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 25952732 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | stem cell transplantation | NA | NA | NA | unclassified | |
| natural killer (nk) cells that express self-hla-specific receptors (where hla is human leukocyte antigen) are "licensed" and more readily activated than unlicensed cells; therefore, nk-cell licensing could influence the antileukemia effects of nk cells following haploidentical stem cell transplantation (haplo-sct). | |||||||
| 26010044 | NA (NA) | stem cell transplantation | NA | NA | NA | unclassified | |
| non-hla genomics: does it have a role in predicting haematopoietic stem cell transplantation outcome? | |||||||
| 26018555 | HLA (HLA) | stem cell transplantation | NA | NA | NA | unclassified | |
| the clinical impact of achieving this level of resolution hla typing data is likely to considerable, particularly in applications such as organ and blood stem cell transplantation where matching donors and recipients for their hla is of utmost importance. | |||||||
| 26214138 | HLA (HLA) | rs1800795 | NA | rs8177374 | rs9340799 | unclassified | |
| NA | |||||||
| 26367234 | HLA IDENTICAL (HLA-IDENTICAL) | stem cell transplantation | NA | NA | NA | unclassified | |
| ugt2b17 minor histocompatibility mismatch and clinical outcome after hla-identical sibling donor stem cell transplantation. | |||||||
| 26415558 | HLA MATCHED (HLA-MATCHED) | stem cell transplantation | NA | cyclophosphamide | NA | unclassified | |
| haploidentical stem cell transplantation (sct) offers a transplantation option to patients who lack an hla-matched donor. | |||||||
| 26478549 | HLA IDENTICAL (HLA-IDENTICAL) | stem cell transplantation | NA | NA | NA | unclassified | |
| therefore it was decided to perform a non-myeloablative allogeneic haematopoietic stem cell transplantation, with his hla-identical brother as donor. | |||||||
| 26528768 | HLA (HLA) | stem cell transplantation | NA | cyclophosphamide | NA | unclassified | |
| impact of thymoglobulin by stem cell source (peripheral blood stem cell or bone marrow) after myeloablative stem cell transplantation from hla 10/10-matched unrelated donors: a report from the societe francaise de greffe de moelle et de therapie cellulaire. | |||||||
| 26529865 | HLA MATCHED (HLA-MATCHED) | stem cell transplantation | NA | NA | NA | unclassified | |
| only 69 patients (4.5%) received treatment with hla-matched sibling stem cell transplantation and another 232 (15.5%) patients received atg plus cyclosporine as immunosuppressive therapy. | |||||||
| 26688192 | HLA MATCHED (HLA-MATCHED) | stem cell transplantation | NA | NA | NA | unclassified | |
| immune reconstitution kinetics and subsequent clinical outcomes in hla-matched recipients of allogeneic stem cell transplantation (sct) are variable and difficult to predict. | |||||||
Copyright 2024